TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidence of All Bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Delayed Graft Function and Slow Graft Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Premature Infant Pain Profile (PIPP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obsessive compulsive disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in total score for objective clinical signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DSM-IV diagnosis of PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Lactate Levels correlated with survival
Endpoint domain: Mortality/survival
Primary endpoint: Blood Lactate Levels correlated with Neurological Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average Intraoperative Temperature Greater Than or Equal to 36 Celsius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial PACU Sublingual Temperature of ≥ 36º C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Sublingual Temperature Above 36 Degrees Celsius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Plasma Genotyping Assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of caries lesions which progressed to dentine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Actual birth weight prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percentage of change in the number of scalp actinic keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Cardiac Global Longitudinal Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change from length of sleep at one week
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: change from Pittsburgh sleep quality index scale at one week
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: change from Parkinson's disease quality of life scale one week
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Microbiota composition in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiota composition in breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-caloric sweeteners levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiologic responses to opioid medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal Percent Reduction in Serum Monoclonal Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remifentanil consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pure-tone Threshold Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infants' intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patterning of feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Response Using RECIST Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose/Recommended Dose (MTD/RD)
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Engagement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Blood pressure (SBP and DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Corneal epithelial defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Complete Response
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants With Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Event of SAE and Treatment-related Severe AE
Endpoint domain: Adverse events/effects
Primary endpoint: Common bile duct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Students confidence in using iExaminer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Asthma-related patient-reported quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical sedation score (N-PASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude-integrated EEG (aEEG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emergency department mortality
Endpoint domain: Mortality/survival
Primary endpoint: emergency department length of stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: # of E.D. visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: # of hospital re-admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Lucentis injections
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With HEPLISAV-B Seroprotective Titer (Anti-HBs 10mIU/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cmax of dexpramipexole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of dexpramipexole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of intact perineum after childbirth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Effectiveness and accuracy of quantitative liver function testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite pharyngolaryngeal complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major cardiac complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Significant Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean value of post exercise ABI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants With Clinical Signs/Symptoms Indicating TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events of autologous peripheral blood mononuclear cell mobilization
Endpoint domain: Adverse events/effects
Primary endpoint: plasma FGF19 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma bile salt levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: itch intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in North Star Ambulatory Assessment (NSAA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste Preference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histopathological analyses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genomic Features of Pre-Malignant Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Microenvironmental Features of Lung Pre-Malignant Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Salivary bacterial CFU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiologic efficacy of linezolid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in time taken to complete a one mile walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fractional DNL (% new palmitate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline over time in adiponectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline over time in leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in scapular orientation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in weight (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in waist circumference (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in body mass index (BMI z score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fluid balance within 24 hours after presence of acute cardiogenic pulmonary edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of implantable devices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of drug using days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from Baseline HIV and other STI risk at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from Baseline in HIV and Other STI Risk at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in total exercise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Peri-operative and Post-operative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: First Occurrence of Any Component of Composite MACE
Endpoint domain: Mortality/survival
Primary endpoint: Vaginal birth
Endpoint domain: Mortality/survival
Primary endpoint: Vaccine-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Progression-free Survival (Percentage of Participants Alive Without Progression)
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival (Percentage of Participants Alive)
Endpoint domain: Mortality/survival
Primary endpoint: Changes in measures of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in measures of stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in measures of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Obstetrical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Concentration of telavancin estimated by antibiotic potency bioassay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of telavancin determined by LC/MS/MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Girdle Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Patients Experiencing Biopsy Confirmed Acute Rejection
Endpoint domain: Adverse events/effects
Primary endpoint: ENS pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's actual physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer's test type II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knowledge and intentions to obtain the HPV vaccine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with treatment related Adverse events grade IIIb or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Depressive Symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in modified VASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central Sensitization Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adolescent/Adult Sensory Profile score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in 6 minute hall walk test from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms measured with the Minnesota Living With Heart Failure(MLWHF) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Subject Rating of Breathing Discomfort (Dyspnea)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Depressive Symptoms self rated
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depressive Symptoms physician rated
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in symptoms of mesenteric panniculitis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Acuity Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in body composition (muscle mass, fat mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral clearance of prednisolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Electrocardiogram (ECG) Data Met Criteria of Potential Clinical Concern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Life Inventory (PedsQL 4.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area Under the receiver operating characteristic curve (ROC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of children given pain medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Colonization rates with ESBL-producing Enterobacteriaceae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in the Child Adjustment and Parent Efficacy Scale Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Level of knowledge about contraceptive methods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quantity of contraceptive counseling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants counseled on contraception
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: reduction in HAM-D score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduced number of oral cells with mutant p53
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical attachment Level gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual cancer burden (RCB 0-I rates)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Defect Healing - Plain Radiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Defect Healing - Computed Tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prognostic score after endoscopic subcostal dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of study subjects with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in BOLD responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eosinophil per cent of cells recovered in lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Perceived romantic relationship skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Monthly earnings, administrative records
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Economic hardship
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Number of participants with good quality of dietary fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient oriented cardiac events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraoperative surgical field quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 90-day quantitative buttock lift
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 180-day quantitative buttock lift
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 270-day quantitative buttock lift
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Days to reach full enteral feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement of atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Biphasic Alcohol Effects Scale (BAES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weinstein Enhanced sensory test (WEST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of transdermal nicotine patch
Endpoint domain: Adverse events/effects
Primary endpoint: Change in postprandial ghrelin responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in postprandial GLP-1 responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in postprandial PYY responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cleft phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Unified Parkinson's Disease Rating Scale (UPDRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants with Dose-Limiting Toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of DLT as Assessed by NCI-CTCAE
Endpoint domain: Adverse events/effects
Primary endpoint: Blood-brain barrier alteration during migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral blood flow alteration during migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting-state functional brain connectivity alteration during migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Voxel-based morphometry alteration during migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of visual field scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: StO2 levels during occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of Ocular Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hb Concentration (g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: oral status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of RO6889678
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve up to the Last Measurable Concentration (AUC0-last) of RO6889678
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Delivery of ALD-401
Endpoint domain: Adverse events/effects
Primary endpoint: change in quality of life and life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in motivation for returning to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: actual return to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: changes in gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Best Spectacle-corrected Visual Acuity (BSCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year Overall Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Catheter free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Who Experienced DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: Parenting Sense of Competence - Satisfaction Sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parenting Sense of Competence - Efficacy Sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: p-glucagon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes